ArticleJournal of cellular and molecular medicine2026
Honokiol and Magnolol Exert an Anti-Inflammatory Effect by Inhibiting JAK2/STAT3/IL17 Signalling in a Rat Model of Ulcerative Colitis: A Combination of Bioinformatics and Experimental Study.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A facile antibody-mediated CMC platform for targeted screening of CCR1 ligands fromJournal of pharmaceutical analysis · 2026Article
- The Synergistic Neuroprotective Effect of Honokiol and Magnolol Against Amyloid-β and MPPInternational journal of molecular sciences · 2026Article
- Honokiol Ameliorates LPS/D-GalN-Induced Acute Liver Failure via Activation of SIRT3/AMPK and Keap1/Nrf2/HO-1 Signaling and Inhibition of the NF-κB/NLRP3 Inflammasome Axis.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Ulcerative colitis (UC) is a chronic, inflammatory bowel disease with limited clinical treatment. Traditional Chinese medicinal ingredients honokiol and magnolol have potential anti-inflammatory and gastrointestinal protective effects. However, their anti-inflammatory potential has not been investigated in UC. This study hypothesized that honokiol and magnolol alleviate UC by targeting key inflammatory signalling pathways. To verify this, we established a 2,4-dinitrobenzenesulfonic acid-induced UC rat model and administered honokiol and magnolol orally. The results showed that the two ingredients significantly reduced the disease activity index and colonic mucosal damage index and downregulated serum levels of pro-inflammatory factors TNF-α, IL-17, and CRP. Histopathological examination showed marked alleviation of colonic mucosal hyperemia, inflammatory infiltration, and ulcerative damage following honokiol and magnolol treatment. Bioinformatics analysis identified 74 UC-related targets for honokiol and 62 for magnolol, which were enriched in inflammatory response and JAK-STAT/IL-17 signalling pathways. A gradient boosting machine model was established to screen 16 shared hub targets, among which IL17A, JAK2, and STAT3 were highly correlated with immune cell infiltration. Molecular docking confirmed that honokiol and magnolol could stably bind to key proteins of the JAK-STAT pathway via noncovalent interactions with low binding energy. Immunohistochemistry and Western blot further verified that both ingredients significantly inhibited the activation of IL17A, JAK2, and STAT3 in the colonic tissues of UC rats. This study demonstrates that honokiol and magnolol exert anti-inflammatory effects in UC rats by inhibiting the JAK2/STAT3/IL17 pathway, providing a mechanistic basis and potential targets for the application of traditional Chinese medicinal ingredients in UC treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.